Engineers Gate Manager’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-142,362
Closed -$611K 2494
2026
Q1
$611K Buy
+142,362
New +$793K 0.01% 1293
2025
Q4
Sell
-57,080
Closed -$211K 2403
2025
Q3
$211K Buy
+57,080
New +$156K ﹤0.01% 1887
2024
Q1
Sell
-11,306
Closed -$17.1K 2188
2023
Q4
$17.1K Sell
11,306
-20,861
-65% -$26.8K ﹤0.01% 1913
2023
Q3
$43.1K Buy
32,167
+18,689
+139% +$31.1K ﹤0.01% 1665
2023
Q2
$24.3K Sell
13,478
-4,914
-27% -$8.35K ﹤0.01% 1660
2023
Q1
$30.5K Buy
+18,392
New +$37.3K ﹤0.01% 1577
2021
Q3
Sell
-21,667
Closed -$202K 1866
2021
Q2
$202K Buy
+21,667
New +$247K 0.01% 1401

Other funds holding NUVB

Engineers Gate Manager's NUVB Position: Q2 2026 in Review

Engineers Gate Manager sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 142,362 shares — an estimated $611K sold.

Engineers Gate Manager first reported a position in NUVB in Q2 2021 and held it in 7 quarters. The position peaked at $611K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Engineers Gate Manager reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 142,362 Nuvation Bio shares in Q2 2026, an estimated $611K.
  • Engineers Gate Manager first reported a position in Nuvation Bio in Q2 2021 and held it in 7 quarters.
  • Engineers Gate Manager's Nuvation Bio position peaked at $611K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.